Market revenue in 2023 | USD 166.8 million |
Market revenue in 2030 | USD 254.4 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Purity>98% |
Fastest growing segment | Purity>98% |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Purity>98%, Purity<98% |
Key market players worldwide | Merck KGaA, GSK PLC, Cipla Ltd DR, Novartis AG ADR, Sanofi SA, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Mallinckrodt PLC Ordinary Shares - New, Cayman Chemical, Tokyo Chemical Industry, APExBIO Technology, Wilshire Technologies, Biosynth |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crocin market will help companies and investors design strategic landscapes.
Purity>98% was the largest segment with a revenue share of 95.5% in 2023. Horizon Databook has segmented the Canada crocin market based on purity>98%, purity<98% covering the revenue growth of each sub-segment from 2018 to 2030.
Acetaminophen is widely used in Canada for the treatment of pain and fever. It is found in over 700 OTC and prescription medications to treat muscle pain, allergies, cold & flu symptoms, and menstrual cramps.
Moreover, the use of the product is increasing owing to the growing prevalence of migraines and headaches. However, there have been shortages over the years in the country. Thus, a large volume of acetaminophen is imported into the country.
In late 2022 and early 2023, Canada experienced a shortage of ibuprofen and acetaminophen due to unprecedented demand in the 2022 cold and flu season to manage infant & children’s pain & fever. To counter this, local manufacturers increased the production of acetaminophen and ibuprofen from November 2022 to May 2023 and released 13.9 million units.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada crocin market , including forecasts for subscribers. This country databook contains high-level insights into Canada crocin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account